(OTCBB: TCNH)
|
Technest Holdings, Inc. Profile
|
|
Technest Holdings, Inc. ("Technest" or "the Company") is engaged in the design, research and development (R&D), integration, analysis, modeling, system networking, sales, and support of intelligent surveillance, three-dimensional (3D) facial recognition, and 3D imaging devices and systems. In a post-9/11 world, there is little doubt that threats against the U.S. exist and that one of the most effective methods of protecting this country is through continued development and advancement of security-based technology. With sophisticated engineering and R&D, Technest offers differentiated products and services based on several core technology platforms, including 3D imaging, intelligent surveillance, and 3D facial recognition. Technest operates as two basic components: (1) an incubator for emerging security technologies in the final stages of development, and (2) an acquirer of revenue-generating assets in the security marketplace that have historical positive cash flow but have not yet been optimized. Sitting between a government customer with a long list of needs for fully-integrated solutions and a world of state-of-the-art technology that, alone, has very little value to the consumer, Technest aims to bridge this gap and transform laboratory technology into real-world products. The Company seeks to become a leading supplier of advanced imaging solutions, and recently agreed to sell one of its wholly owned subsidiaries, EOIR Technologies, Inc., while aiming to consolidate its 3D imaging position at Technest through a second wholly owned subsidiary, Genex Technologies, Inc. Technest's largest customers are the Department of Defense (DOD) and the National Institutes of Health (NIH), reflecting the Company's focus on products for the security and healthcare industries. After the anticipated sale of EOIR, Technest intends to broaden its offerings in the healthcare as well as commercial markets.
|
|
